HEADER TRANSFERASE 16-JAN-08 3BYO TITLE X-RAY CO-CRYSTAL STRUCTURE OF 2-AMINO-6-PHENYLPYRIMIDO[5',4':5, TITLE 2 6]PYRIMIDO[1,2-A]BENZIMIDAZOL-5(6H)-ONE 25 BOUND TO LCK COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: P56-LCK, LYMPHOCYTE CELL-SPECIFIC PROTEIN-TYROSINE KINASE, COMPND 6 LSK, T CELL-SPECIFIC PROTEIN-TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LCK; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: INSECT CELL KEYWDS LCK, KINASE DOMAIN, ALTERNATIVE SPLICING, ATP-BINDING, CHROMOSOMAL KEYWDS 2 REARRANGEMENT, CYTOPLASM, DISEASE MUTATION, HOST-VIRUS INTERACTION, KEYWDS 3 LIPOPROTEIN, MEMBRANE, MYRISTATE, NUCLEOTIDE-BINDING, PALMITATE, KEYWDS 4 PHOSPHOPROTEIN, PROTO-ONCOGENE, SH2 DOMAIN, SH3 DOMAIN, TRANSFERASE, KEYWDS 5 TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR X.HUANG REVDAT 4 15-NOV-23 3BYO 1 REMARK REVDAT 3 30-AUG-23 3BYO 1 REMARK LINK REVDAT 2 02-MAR-10 3BYO 1 SOURCE REVDAT 1 30-DEC-08 3BYO 0 JRNL AUTH M.W.MARTIN,J.NEWCOMB,J.J.NUNES,C.BOUCHER,L.CHAI,L.F.EPSTEIN, JRNL AUTH 2 T.FAUST,S.FLORES,P.GALLANT,A.GORE,Y.GU,F.HSIEH,X.HUANG, JRNL AUTH 3 J.L.KIM,S.MIDDLETON,K.MORGENSTERN,A.OLIVEIRA-DOS-SANTOS, JRNL AUTH 4 V.F.PATEL,D.POWERS,P.ROSE,Y.TUDOR,S.M.TURCI,A.A.WELCHER, JRNL AUTH 5 D.ZACK,H.ZHAO,L.ZHU,X.ZHU,C.GHIRON,M.ERMANN,D.JOHNSTON, JRNL AUTH 6 C.G.SALUSTE JRNL TITL STRUCTURE-BASED DESIGN OF NOVEL JRNL TITL 2 2-AMINO-6-PHENYL-PYRIMIDO[5',4':5,6]PYRIMIDO[1, JRNL TITL 3 2-A]BENZIMIDAZOL-5(6H)-ONES AS POTENT AND ORALLY ACTIVE JRNL TITL 4 INHIBITORS OF LYMPHOCYTE SPECIFIC KINASE (LCK): SYNTHESIS, JRNL TITL 5 SAR, AND IN VIVO ANTI-INFLAMMATORY ACTIVITY. JRNL REF J.MED.CHEM. V. 51 1637 2008 JRNL REFN ISSN 0022-2623 JRNL PMID 18278858 JRNL DOI 10.1021/JM701095M REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 19888 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1018 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2192 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 224 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.690 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3BYO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-JAN-08. REMARK 100 THE DEPOSITION ID IS D_1000046121. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19888 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 3.630 REMARK 200 R MERGE (I) : 0.09200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.24200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1QPC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M LI2SO4, 25-35% PEG4000, PH 8.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.06700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.33400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.77200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 46.33400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.06700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.77200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 309 CG CD OE1 NE2 REMARK 470 ARG A 397 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 401 CG CD CE NZ REMARK 470 GLN A 451 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 363 -7.81 72.80 REMARK 500 ASP A 382 85.04 55.13 REMARK 500 ASP A 391 -99.28 -108.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AM9 A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3BYM RELATED DB: PDB DBREF 3BYO A 231 501 UNP P06239 LCK_HUMAN 231 501 SEQRES 1 A 271 LYS PRO TRP TRP GLU ASP GLU TRP GLU VAL PRO ARG GLU SEQRES 2 A 271 THR LEU LYS LEU VAL GLU ARG LEU GLY ALA GLY GLN PHE SEQRES 3 A 271 GLY GLU VAL TRP MET GLY TYR TYR ASN GLY HIS THR LYS SEQRES 4 A 271 VAL ALA VAL LYS SER LEU LYS GLN GLY SER MET SER PRO SEQRES 5 A 271 ASP ALA PHE LEU ALA GLU ALA ASN LEU MET LYS GLN LEU SEQRES 6 A 271 GLN HIS GLN ARG LEU VAL ARG LEU TYR ALA VAL VAL THR SEQRES 7 A 271 GLN GLU PRO ILE TYR ILE ILE THR GLU TYR MET GLU ASN SEQRES 8 A 271 GLY SER LEU VAL ASP PHE LEU LYS THR PRO SER GLY ILE SEQRES 9 A 271 LYS LEU THR ILE ASN LYS LEU LEU ASP MET ALA ALA GLN SEQRES 10 A 271 ILE ALA GLU GLY MET ALA PHE ILE GLU GLU ARG ASN TYR SEQRES 11 A 271 ILE HIS ARG ASP LEU ARG ALA ALA ASN ILE LEU VAL SER SEQRES 12 A 271 ASP THR LEU SER CYS LYS ILE ALA ASP PHE GLY LEU ALA SEQRES 13 A 271 ARG LEU ILE GLU ASP ASN GLU PTR THR ALA ARG GLU GLY SEQRES 14 A 271 ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU ALA ILE SEQRES 15 A 271 ASN TYR GLY THR PHE THR ILE LYS SER ASP VAL TRP SER SEQRES 16 A 271 PHE GLY ILE LEU LEU THR GLU ILE VAL THR HIS GLY ARG SEQRES 17 A 271 ILE PRO TYR PRO GLY MET THR ASN PRO GLU VAL ILE GLN SEQRES 18 A 271 ASN LEU GLU ARG GLY TYR ARG MET VAL ARG PRO ASP ASN SEQRES 19 A 271 CYS PRO GLU GLU LEU TYR GLN LEU MET ARG LEU CYS TRP SEQRES 20 A 271 LYS GLU ARG PRO GLU ASP ARG PRO THR PHE ASP TYR LEU SEQRES 21 A 271 ARG SER VAL LEU GLU ASP PHE PHE THR ALA THR MODRES 3BYO PTR A 394 TYR O-PHOSPHOTYROSINE HET PTR A 394 16 HET SO4 A 2 5 HET AM9 A 1 40 HETNAM PTR O-PHOSPHOTYROSINE HETNAM SO4 SULFATE ION HETNAM AM9 6-(2,6-DIMETHYLPHENYL)-2-{[4-(4-METHYLPIPERAZIN-1-YL) HETNAM 2 AM9 PHENYL]AMINO}PYRIMIDO[5',4':5,6]PYRIMIDO[1,2- HETNAM 3 AM9 A]BENZIMIDAZOL-5(6H)-ONE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR C9 H12 N O6 P FORMUL 2 SO4 O4 S 2- FORMUL 3 AM9 C31 H30 N8 O FORMUL 4 HOH *224(H2 O) HELIX 1 1 PRO A 241 GLU A 243 5 3 HELIX 2 2 SER A 281 LEU A 295 1 15 HELIX 3 3 SER A 323 LEU A 328 1 6 HELIX 4 4 THR A 330 LEU A 336 1 7 HELIX 5 5 THR A 337 ARG A 358 1 22 HELIX 6 6 ARG A 366 ALA A 368 5 3 HELIX 7 7 ALA A 408 GLY A 415 1 8 HELIX 8 8 THR A 418 THR A 435 1 18 HELIX 9 9 THR A 445 ARG A 455 1 11 HELIX 10 10 PRO A 466 TRP A 477 1 12 HELIX 11 11 ARG A 480 ARG A 484 5 5 HELIX 12 12 THR A 486 THR A 501 1 16 SHEET 1 A 5 LEU A 245 GLY A 254 0 SHEET 2 A 5 GLY A 257 TYR A 264 -1 O MET A 261 N GLU A 249 SHEET 3 A 5 THR A 268 LEU A 275 -1 O VAL A 272 N TRP A 260 SHEET 4 A 5 TYR A 313 GLU A 317 -1 O ILE A 314 N LYS A 273 SHEET 5 A 5 LEU A 303 VAL A 307 -1 N TYR A 304 O ILE A 315 SHEET 1 B 2 TYR A 360 ILE A 361 0 SHEET 2 B 2 ARG A 387 LEU A 388 -1 O ARG A 387 N ILE A 361 SHEET 1 C 2 ILE A 370 VAL A 372 0 SHEET 2 C 2 CYS A 378 ILE A 380 -1 O LYS A 379 N LEU A 371 SHEET 1 D 2 PTR A 394 THR A 395 0 SHEET 2 D 2 THR A 416 PHE A 417 -1 O PHE A 417 N PTR A 394 LINK C GLU A 393 N PTR A 394 1555 1555 1.33 LINK C PTR A 394 N THR A 395 1555 1555 1.32 CISPEP 1 GLU A 310 PRO A 311 0 -0.29 SITE 1 AC1 9 GLN A 298 ARG A 299 SER A 377 LYS A 379 SITE 2 AC1 9 TYR A 457 ARG A 458 HOH A 509 HOH A 566 SITE 3 AC1 9 HOH A 575 SITE 1 AC2 13 LEU A 251 ALA A 271 LYS A 273 GLU A 288 SITE 2 AC2 13 THR A 316 GLU A 317 TYR A 318 MET A 319 SITE 3 AC2 13 GLY A 322 LEU A 371 ASP A 382 HOH A 565 SITE 4 AC2 13 HOH A 571 CRYST1 42.134 73.544 92.668 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023734 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013597 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010791 0.00000